Quantcast

Posts related to ‘CRME’

NASDAQ Changes Up Biotech Index Members & Weightings

Index changes are generally speaking a fairly routine event.  They can also create underlying moves in the companies added and deleted from them as money management firms often buy and ...
Read Full Story »

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled further development of an oral version of a Cardiome drug ...
Read Full Story »

Top Active Trader Alerts (BRCD, BKC, WEN, CRME, MPEL, OREX, PAR)

There are several stocks on the move that will be the focus of active traders and day traders on Thursday morning.  The stocks on the move are Brocade Communications Systems, ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading:Abbott Laboratories (NYSE: ABT) Raised To Outperform at Wachovia.Altria (NYSE: MO) started as Buy ...
Read Full Story »

Biotech Movers & Shakers (AMGN, CRME, DNDN, GNVC, DNA, QLTI, TBRN, BBH, XBI)

Biotech’s are sliding along with all the others today. A look at the highlights and outliers:Amgen (NASDAQ: AMGN) and Wyeth (NYSE: WYE) announced that arthritis and psoriasis drug Enbrel will ...
Read Full Story »

A Lucky Day at Cardiome Pharma (CRME)

Cardiome Pharma (NASDAQ: CRME) picked a bad day for good news.According to the AP the company announced "interim midstage data showed its experimental drug vernakalant was safe and effective in ...
Read Full Story »